For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of MSD. Through its commitment to the Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets
MSD said the product will make vaccination more convenient, helping improve levels of compliance against variant strains of RHD, which is estimated to be at around 60% of the vaccinated rabbit population. A single low volume 0.5ml vaccination provides 12 months’ duration of immunity against all three pathogens. Available in a pack of five single-dose vials, with a shelf life of two years, the vaccine can be used from the age of five weeks old or seven weeks old onwards to achieve the full duration of immunity. Immunity is provided within three weeks of administration.
Features of 3 In 1 Rabbit Vaccine
Nobivac Myxo-RHD Plus is a vaccine used in rabbits to reduce death and clinical signs due to myxomatosis and rabbit haemorrhagic disease (RHD). Myxomatosis is caused by the myxoma virus and is spread between rabbits by close contact and biting insects such as fleas and mosquitoes. The virus causes swelling and discharge from the eyes, nose and bottom with most rabbits dying within 10 – 14 days. RHD, caused by classical RHD virus (RHDV1) and RHD type 2 virus (RHDV2), leads to blood clots in major organs such as the heart, lungs and kidneys leading to heart and respiratory failure when the heart and lungs do not work properly. Nobivac Myxo-RHD Plus contains live myxoma vectored RHD virus strains 009 and MK1899.
Mode of action
Nobivac Myxo-RHD Plus is a vaccine. Vaccines work by preparing the immune system (the body’s natural defences) to defend itself against a specific disease. Nobivac Myxo-RHD Plus contains small amounts of weakened forms of the myxoma virus that causes myxomatosis. These viruses have been modified so that they also produce proteins from the outer coat of either RHDV1 (strain 009) or RHDV2 (strain MK1899). When a rabbit is given the vaccine, the immune system recognises the weakened viruses in the vaccine as ‘foreign’ and makes antibodies against both the myxoma virus and the RHD virus proteins. When the rabbit comes into contact with these or similar viruses, these antibodies, together with other components of the immune system, will be able to kill the viruses and help protect against the diseases.
The withdrawal period is the time required after administration of a medicine before an animal can be slaughtered and the meat used for human consumption.
The withdrawal period for meat from rabbits treated with Nobivac Myxo-RHD Plus is ‘zero’ days, which means that there is no mandatory waiting time.
Prices of 3 In 1 Rabbit Vaccine